Gujarat Kidney & Super Speciality

ClosedIssue Size ₹ 250 CrGMP ₹ 122Gain 7.02%Updated 30 Dec 25, 06:00:03 pm
Last updated: 30 Dec 2025
Share:
ISSUE PRICE
₹ 114
Per Share
CURRENT GMP
₹ 122
(Issue + Premium)
LISTING GAIN EXPECTEDHigh Risk
7.02%
Updated 30 Dec 25, 06:00:03 pm

Bidding Information

Opens
Dec 22, 2025
Closes
Dec 24, 2025
Listing Date
Dec 30, 2025

Company Description

Gujarat Kidney & Super Speciality IPO

Company Overview

Gujarat Kidney & Super Speciality is a healthcare services provider specializing in nephrology, urology, and multi-specialty medical treatments. The hospital focuses on kidney-related diseases, dialysis services, organ transplant support, and advanced super-specialty care. With modern medical infrastructure and a team of experienced doctors and specialists, the institution caters to patients across Gujarat and neighboring regions. The company emphasizes affordable, high-quality healthcare supported by technology-driven clinical practices.



Key Highlights

  • Specialized focus on kidney care, nephrology, and urology services.

  • Strong reputation in super-specialty treatments and critical care.

  • Advanced dialysis facilities and transplant support services.

  • Growing patient base driven by rising kidney-related health issues.

  • Experienced medical professionals and skilled support staff.

  • Emphasis on affordable treatment with high clinical standards.


IPO Objective

  • Expansion of hospital infrastructure and bed capacity.

  • Upgrading medical equipment and dialysis technology.

  • Strengthening super-specialty departments and critical care units.

  • Meeting working capital requirements for hospital operations.

  • Debt reduction to improve financial stability.

  • General corporate purposes.


Financial Performance

(Detailed financials to be disclosed in DRHP)

  • Steady revenue growth supported by increasing patient inflow.

  • Improved operating margins due to better capacity utilization.

  • Strong cash flows from recurring dialysis and treatment services.

  • Balanced revenue mix across nephrology, urology, and super-specialty care.

  • Controlled cost structure supported by operational efficiencies.


Company Strengths

  • Specialized healthcare focus with strong brand credibility.

  • High patient retention due to chronic care services.

  • Skilled medical team with domain expertise.

  • Modern infrastructure and compliance with healthcare standards.

  • Strategic location serving regional healthcare demand.

  • Patient-centric care model with emphasis on outcomes.


Industry Outlook

India’s healthcare sector is expanding rapidly due to rising lifestyle diseases and improved healthcare awareness. Kidney-related ailments are increasing due to diabetes and hypertension, driving sustained demand for dialysis and nephrology services. Government healthcare schemes, insurance penetration, and private hospital expansion continue to support long-term growth for specialized healthcare providers like Gujarat Kidney & Super Speciality.

Check Your Allotment Status

Verify if shares have been allocated to your application

Check Allotment Status

Frequently Asked Questions

Common questions about Gujarat Kidney & Super Speciality IPO

What is the current GMP of Gujarat Kidney & Super Speciality IPO?

The current Grey Market Premium (GMP) of Gujarat Kidney & Super Speciality IPO is ₹122. This indicates an expected listing gain of approximately 7.02% over the issue price of ₹114. GMP reflects unofficial market sentiment and can fluctuate based on demand and market conditions.

When is the allotment date for Gujarat Kidney & Super Speciality IPO?

The allotment date for Gujarat Kidney & Super Speciality IPO is Dec 29, 2025. The IPO listing is scheduled for Dec 30, 2025. You can check your allotment status on the registrar's website once the allotment is finalized.

Is Gujarat Kidney & Super Speciality IPO good for long-term investment?

Gujarat Kidney & Super Speciality IPO shows a current GMP of ₹122 with an expected listing gain of 7.02%. However, investment decisions should be based on your risk profile, company fundamentals, industry outlook, and financial goals. We recommend reviewing the company's DRHP, financial statements, and competitive position. Always consult with a SEBI registered financial advisor before making investment decisions.

What is the issue price and lot size of Gujarat Kidney & Super Speciality IPO?

Gujarat Kidney & Super Speciality IPO has an issue price of ₹114 per share with a lot size of 128 shares. The total issue size is ₹250 crores. This means the minimum investment required is ₹14,592.

Related IPOs You May Like

Explore similar upcoming and active IPOs

IPO GMP Tracker

Realtime Grey Market Premium Insights

Independent platform aggregating publicly available IPO Grey Market Premium (GMP) data, subscription stats & listing performance to help investors stay informed. Not a SEBI registered advisor. Educational use only.

! Important Disclaimer

Disclaimer: Data compiled from sources believed reliable; no warranty on accuracy, completeness or timeliness. No investment advice, recommendations, solicitation or brokerage activity is provided.

GMP figures are indicative / unofficial & can be volatile. Users must perform their own due diligence. We hold no financial liability for decisions made using information from this site.

Affiliate relationships may exist; we may earn a commission if you sign up via partner links. This does not influence data presentation.

© 2025 IPO GMP Tracker. All rights reserved.